Minimal restsygdom ved maligne blodsygdomme II. Translation og terapeutiske konsekvenser

Autor: Hokland, Peter, Ommen, Hans Beier, Nyvold, Charlotte Guldborg, Stentoft, Jesper, Braendstrup, Karin, Andersen, Bodil Lind, Siig, Lone, Ostergaard, Mette

Publikováno v: Hokland, P, Ommen, H B, Nyvold, C G, Stentoft, J, Braendstrup, K, Andersen, B L, Siig, L & Ostergaard, M 2009, ' Minimal restsygdom ved maligne blodsygdomme II. Translation og terapeutiske konsekvenser ', Ugeskrift for Læger, bind 171, nr. 4, s. 232-5 .

The translation of quantitative polymerase chain reaction technology for the quantitative detection of minimal residual disease (MRD) arising from molecular aberrations in leukaemias has progressed from the pre-clinical setting to daily clinical prac

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pure_au_____::09c436503ce9d6032339fe377b64adc5
https://pure.au.dk/portal/da/publications/minimal-restsygdom-ved-maligne-blodsygdomme-ii-translation-og-terapeutiske-konsekvenser(2c6fada0-01ad-11de-a987-000ea68e967b).html